Meeting program

Translational Approaches to Cardiovascular Research

17:00-17:40 "Size matters: need for large-scale population studies"
Rory Collins (University of Oxford; Biobank, UK)
17:40-18:20 "Role of genetic markers in myocardial infarction"
Pier Mannucci (University of Milan, Italy)
18:20-19:00 "Genome-wide scan in a Sardinian cohort reveals candidate genes associated with quantitative cardiovascular-related traits"
David Schlessinger (National Institute on Aging; National Institutes of Health, USA)
19:30 Welcome cocktail and poster session

Session 2. Genetics and Genomics II
8:30-9:10 "An investment in the future of cardiovascular medicine"
Elizabeth G. Nabel (National Heart, Lung, and Blood Institute; National Institutes of Health, USA)
9:10-9:50 "Transforming the practice of cardiovascular medicine using genomics"
Geoffrey Ginsburg (Duke University, USA)
9:50-10:30 "Molecular dissection of cardiac repolarization and sudden cardiac death"
Aravinda Chakravarti (Johns Hopkins School of Medicine, USA)
10:30-11:00 Coffee break

Session 3. New Tools I (Metabolomics and Proteomics)
11:00-11:40 "Proteomic biomarkers in coronary artery disease"
Anna Dominiczak (University of Glasgow, UK)
11:40-12:20 "Towards a metabolomics platform for cardiovascular disease: insights from planned heart attacks"
Robert Gerszten (Massachusetts General Hospital; Broad Institute, USA)
12:20-13:00 "Applications of metabolomics to diabetes, obesity and cardiovascular disease"
Julian L. Griffin (University of Cambridge, UK)
13:00-15:00 Lunch and poster session

Session 4. New Tools II (Imaging)
15:00-15:40 "Multimodality (pet/ct, mr and ct) imaging of the atherosclerotic plaque and novel nanoparticulate drug delivery: implications for cardiovascular drug design and discovery"
Zahi Fayad (Mount Sinai School of Medicine, USA)
15:40-16:20 Peter Libby (Brigham and Women's Hospital, USA)
16:20-17:00 "Tracking regression and progression of atherosclerosis with intravascular ultrasound"
Stephen J. Nicholls (Cleveland Clinic, USA)
17:00-17:30 Coffee break

Session 5. Advances in Cardiovascular Biology I
17:30-18:10 "MicroRNA regulation of cardiovascular biology and disease"
Deepak Srivastava (University of California - San Francisco, USA)
18:10-18:50 Joseph Metzger (University of Michigan - Ann Arbor, USA)
18:50-19:30 "Postpartum cardiomyopathy: from mice to women"
Helmut Drexler (Hannover Medical School, Germany)
19:30-19:45 "cAMP-dependent neointimal cushion formation in rat ductus arteriosus"
Susumu Minamisawa (Waseda University, Japan)
19:45-20:00 "Akt is a determinant for L-type calcium channel protein stability and cardiac contraction"
Daniele Catalucci (Fondazione Parco Biomedico San Raffaele, Italy)

Session 7. New Therapeutic Strategies I
11:00-11:40 "The nitrite-nitric oxide pathway in physiology and therapeutics"
Mark Gladwin (National Heart, Lung, and Blood Institute; National Institutes of Health, USA)
11:40-12:20 "Oxidative enzymopathies in cardiovascular disease"
Joseph Loscalzo (Brigham and Women's Hospital; Harvard Medical School, USA)
12:20-12:35 "Identifying genes which control collateral vessel development in zebrafish embryos"
Tim Chico (University of Sheffield UK)
12:35-12:50 "Trpv4 and Abra: novel factors determine the growth of collateral vessels in response to arterial occlusions (arteriogenesis)"
Kerstin Troidl (Max-Planck-Institute for Heart and Lung Research, Germany)
12:50-15:00 Lunch and poster session

Session 8. New Therapeutic Strategies II
15:00-15:40 "New developments in gene therapy for heart failure"
Roger Hajjar (Mount Sinai School of Medicine, USA)
15:40-16:20 Tullio Pozzan (University of Padova, Italy)
16:20-17:00 "Autologous progenitor cell therapy for acute myocardial infarction"
Andreas M. Zeiher (J.W. Goethe University, Germany)
17:00-17:30 Coffee break